This animal model study examined alpha-melanocyte-stimulating hormone (alpha-MSH) related peptides, including KPV, as potential anti-inflammatory and immunomodulating agents for treating rheumatic diseases. The research found that these peptides demonstrated anti-inflammatory properties and immunomodulatory effects in animal systems, suggesting a novel therapeutic class for conditions like rheumatoid arthritis. This evidence is derived from animal model research and represents an early stage of investigation prior to human clinical application.